Literature DB >> 8557916

Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgment?

B J Maron.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8557916     DOI: 10.1016/0735-1097(95)00463-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

Review 1.  Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy.

Authors:  H Seggewiss
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

Review 2.  Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.

Authors:  Angelos G Rigopoulos; Stefanos Sakellaropoulos; Muhammad Ali; Sophie Mavrogeni; Athanassios Manginas; Matthias Pauschinger; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

3.  Percutaneous myocardial ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy.

Authors:  I Tengiz; E Ercan; U O Türk
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-12       Impact factor: 2.357

Review 4.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

5.  Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy.

Authors:  Hubert Seggewiss
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

Review 6.  [Clinical picture and therapy of hypertrophic cardiomyopathy].

Authors:  U Gleichmann; H Seggewiss
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 7.  Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Angelos G Rigopoulos; Hubert Seggewiss
Journal:  Curr Cardiol Rev       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.